![](https://s3.amazonaws.com/cache.altmetric.com/policy/thumbnails/thumbnail-0bd0c02d2ca7cf77b940a770e95df1b3967d9a42edcee61ef0384611e49d139e.jpg)
Melatonin for the Treatment of Insomnia: A 2022 Update
Cited by Canadian Agency for Drugs and Technologies in Health on
CADTH is an independent, not-for-profit organization responsible for providing health care decision-makers with objective evidence to help make informed decisions about the optimal use of health technologies.